Skip to main content

Vroman Ken's Form 4 filing

CME Group Inc. (CME) · filed Sep 17, 2026

Accession no.
0001429863-26-000003
Filed
Sep 17, 2026, 4:28 PM ET
Trade date
Sep 15-16, 2026
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 5 non-derivative transactions. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Vroman KenCIK 0001429863Officer (Chief Transformation Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Sep 15, 2026Common Stock Class AAGrant or awardAcquired+2,592$275.09+$713,033.2821,443Direct
Sep 15, 2026Common Stock Class AFTax withholdingDisposed−320$275.09−$88,028.821,123Direct
Sep 15, 2026Common Stock Class AFTax withholdingDisposed−309$275.09−$85,002.8120,814Direct
Sep 15, 2026Common Stock Class AFTax withholdingDisposed−274$275.09−$75,374.6620,540Direct
Sep 16, 2026Common Stock Class AFTax withholdingDisposed−308$272.46−$83,917.6820,232Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)